Artelo Biosciences (ARTL)
(Delayed Data from NSDQ)
$9.48 USD
-0.45 (-4.53%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $9.54 +0.06 (0.63%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Dividend Yield (TTM)
Artelo Biosciences, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
ARTL 9.48 -0.45(-4.53%)
Will ARTL be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ARTL based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ARTL
New Strong Sell Stocks for April 10th
New Strong Sell Stocks for March 28th
ARTL: What are Zacks experts saying now?
Zacks Private Portfolio Services
New Strong Sell Stocks for March 6th
Other News for ARTL
Artelo Biosciences (ARTL): D. Boral Capital Adjusts Price Target, Maintains Buy Rating | ARTL ...
ARTL Implements Innovative Treasury Strategy with New Securities Purchase Agreement
Artelo Biosciences Announces $9.475 Million At-the-Market Private Placement to Initiate Solana ...
Artelo Biosciences announces private placement to initiate Solana treasury
Artelo Biosciences (ARTL) Advances ART12.11 with UK Regulatory Support